Tony: Thanks for the posts.
Be interesting to know who they are working with inside DF.
I found this Dec2015 article on work by the Stegmaier Group (Dana Farber/Boston Children's Cancer and Blood Disorders program) into AML an interesting read.
http://www.dana-farber.org/Newsroom...and-compounds-for-acute-myeloid-leukemia.aspx
This next link shows Dana Farber/Boston Children's Cancer and Blood Disorders program is rated #1 in the US.
http://www.danafarberbostonchildrens.org/news/us-news-2015.aspx
and here's the Boulder Peptide Symposium page I sourced the RH video:
http://boulderpeptide.org/bps-2015-proceedings-with-videos
SoT
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.26 |
Change
-0.035(2.70%) |
Mkt cap ! $734.9M | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.31 | $1.26 | $2.681M | 2.075M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3081 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 700 | 1 |
View Market Depth
| Last trade - 16.11pm 28/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |